Prateek (invests 4Cr in ideas) Agarwal

Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.

Ortella Global Capital (OG Capital) is a venture capital fund dedicated to co-building startups alongside founders. Focused on early and growth-stage investments in consumer and enterprise solutions, OG Capital provides funding and hands-on operational expertise to help businesses profitably hyper-scale to become the next unicorns. With a corpus of INR 300 Cr (US$ 36 Mn), the fund plans to invest in over 20 companies up to INR 15 Cr (US$ 2 Mn) each. OG Capital aims to deliver a 50%+ CAGR/IRR. Nothing herein constitutes an offer to sell, or a solicitation of an offer to buy, any security or product of Ortella Global or any Ortella Global-managed fund.

Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.

Ortella Global Capital (OG Capital) is a venture capital fund dedicated to co-building startups alongside founders. Focused on early and growth-stage investments in consumer and enterprise solutions, OG Capital provides funding and hands-on operational expertise to help businesses profitably hyper-scale to become the next unicorns. With a corpus of INR 300 Cr (US$ 36 Mn), the fund plans to invest in over 20 companies up to INR 15 Cr (US$ 2 Mn) each. OG Capital aims to deliver a 50%+ CAGR/IRR. Nothing herein constitutes an offer to sell, or a solicitation of an offer to buy, any security or product of Ortella Global or any Ortella Global-managed fund.

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddys has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddys leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddys Laboratories has no affiliation or connection to these situations. Dr. Reddys (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com.  Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages.  Writing to complianceofficer@drreddys.com or chiefombudsperson@drreddys.com. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow

We are a sector agnostic fund, with a keen interest in Deep Tech, Climate Tech, AI/ML, & Consumer Internet. We invest anywhere from Pre-Seed to Series A. The fund is run by a group of entrepreneurs turned investors, who have built, scaled and exited successful ventures in the past. As an operator VC, Shastra works closely with portfolio companies to help them scale effectively.